CAS: 133343-34-7; N-Acetyl-S-((2R,3S,4R)-3-Hydroxy-2-((S)-1-Hydroxy-2-Methylpropyl)-4-Methyl-5-Oxopyrrolidine-2-Carbonyl)-L-Cysteine

该化合物是一种选择性的,强大的蛋白质抑制剂,其具体针对20S蛋白质的β5子单位的能力被广泛承认,从而抑制了类似胆碱酯酶的活动. 这种天然产品来自Streptomices细菌, 是研究蛋白质功能,蛋白降解途径和无源蛋白质系统动态的生化和细胞研究的宝贵工具. 其不可逆转的有约束力的机制确保了持续抑制,使得它特别有助于调查血吸附症,细胞循环调节和...

结构式图片

上下游产品

lactacystin allyl ester N-acetylcystein omuralide N-acetyl-L-cystein allyl ester

合成工艺路线路线简述

    N-乙酰-L-半胱氨酸置于四(三苯基膦)钯 甲酸,双(2-氧代-3-恶唑烷基)次磷酰氯,对甲苯磺酸,三乙胺体系中,用 四氢呋喃,二氯甲烷,苯 用作溶剂,化学反应 25.0H,反应生成乳胞素
    参考文献:从d-葡萄糖立体选择性全合成(+)-Lactacystin
    标题:从d-葡萄糖立体选择性全合成(+)-Lactacystin
    摘要:描述了(+)-Lactacystin 1的手性和立体选择性合成,这是具有α,α-二取代的α-氨基酸结构的第一个非蛋白质神经营养因子.使用烯丙基三氯乙酰亚氨酸酯重排(overman重排)作为关键反应,由d-葡萄糖有效地构建了具有1个氮原子的四取代碳的高度官能化的γ-内酰胺部分.
    Doi:10.1016/s0040-4020(97)01015-6

    海关参考信息

    专利信息


    专利号:US-7183417-B2
    优先权日:2004-04-09
    标题:Simple stereocontrolled synthesis of salinosporamide A
    发明人:COREY ELIAS J
    权利人:HARVARD COLLEGE
    摘要:A simple and effective stereocontrolled synthesis of salinosporamide A(1) n nhas been developed which follows the pathway outlined in the FIGURE. The process, the first total synthesis of salinosporamide A, is capable of providing the compound in substantial quantities for further biological studies. In addition to the method of Scheme I, the present invention also includes several novel synthetic intermediate compounds, several intermediate steps of the preferred synthetic process; and the uses of these compounds in the preparation of synthetic derivatives of the compound Salinosporamide A. Salinosporamide A is of special interest as a synthetic target because of its protein in vitro cytotoxic activity against many tumor cell lines (IC 50 values of 10 nM or less).

    专利号:US-2006287520-A1
    优先权日:2005-05-16
    标 题 :Synthesis of salinosporamide A and analogues thereof
    发明人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
    权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
    摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.

    专利号:US-6849743-B2
    优先权日:1997-08-15
    标 题 :Synthesis of clasto-lactacystin β-lactone and analogs thereof
    发明人:SOUCY FRANCOIS; FLAMONDON LOUIS; BEHNKE MARK; ROUSH WILLIAM
    权利人:MILLENNIUM PHARM INC
    摘要:The present invention is directed to an improved synthesis of clasto-lactacystin-β-lactone, and analogs thereof, that proceeds in fewer steps and in much greater overall yield than syntheses described in the prior art. The synthetic pathway relies upon a novel stereospecific synthesis of an oxazoline intermediate and a unique stereoselective addition of a formyl amide to the oxazoline. Also described are novel clasto-lactacystin-β-lactones, and analogs thereof and their use as proteasome inhibitors.

    专利号:US-2003004337-A1
    优先权日:2000-05-04
    标 题 :Efficient lactam synthesis
    发明人:JUNG KYUNG WOON; YOON CHEOL HWAN
    摘要:Lactams, libraries of lactams, and an efficient method of synthesizing a lactam, including a γ-lactam, in which an a-diazoacetamide of the general structure (I) is reacted under conditions promoting intramolecular C-H insertion, for example in the presence of a rhodium salt such as Rh 2 (OAc) 4 , n n n by which means lactams that are precursors in the synthesis of diverse natural and synthetic products, including pyrrolidinone compounds such as lactacystin, pramanicin, kainic acid, statine, AHPPA, and rolipram, are produced.

    专利号:US-8703812-B2
    优先权日:2005-07-29
    标 题 :Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
    发明人:ALKON DANIEL L
    权利人:ALKON DANIEL L; BRNI NEUROSCIENCES INST
    摘要:The present invention provides methods of contacting a protein kinase C (PKC) activator with a PKC activator in a manner sufficient to stimulate the synthesis of proteins sufficient to consolidate long-term memory. The present invention also provides methods of contacting a protein kinase C (PKC) activator with a PKC activator in a manner sufficient to downregulate PKC.

    专利号:US-6689890-B2
    优先权日:2000-05-04
    标 题:Efficient lactam synthesis
    发明人:JUNG KYUNG WOON; YOON CHEOL HWAN
    权利人:UNIV SOUTH FLORIDA
    摘要:Lactams, libraries of lactams, and an efficient method of synthesizing a lactam, including a gamma-lactam, in which an alpha-diazoacetamide of the general structure (I) is reacted under conditions promoting intramolecular C-H insertion, for example in the presence of a rhodium salt such as Rh2(OAc)4,by which means lactams that are precursors in the synthesis of diverse natural and synthetic products, including pyrrolidinone compounds such as lactacystin, pramanicin, kainic acid, statine, AHPPA, and rolipram, are produced.
    成都曼思特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.cdmust.com
    电话: 028-87384368👤
    📞成都曼思特生物科技有限公司 ⚠️参考联系方式

    销售电话:028-87384368
    邮箱:cdmust@163.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Konieczny J, Czarnecka A, Kamińska K, Lenda T, Nowak P. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA. Behav Brain Res. 2015 Apr 15;283:203-14. doi: 10.1016/j.bbr.2015.01.043. Epub 2015 Feb 2. doi: 10.1111/bph.13208. Epub 2015 Jul 8.
    3: Konieczny J, Jantas D, Lenda T, Domin H, Czarnecka A, Kuter K, Śmiałowska M, Lasoń W, Lorenc-Koci E. Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease. Neurotox Res. 2014 Oct;26(3):255-73. doi: 10.1007/s12640-014-9477-9. Epub 2014 May 20.
    4: Li Y, Gao H, Wang Y, Dai C. Investigation the mechanism of the apoptosis induced by lactacystin in gastric cancer cells. Tumour Biol. 2015 May;36(5):3465-70. doi: 10.1007/s13277-014-2982-x. Epub 2014 Dec 27. doi: 10.1016/j.bbr.2013.12.019. Epub 2013 Dec 17. doi: 10.1016/j.neulet.2014.05.021. Epub 2014 May 23. doi: 10.1016/j.neuroscience.2016.02.072. Epub 2016 Mar 7. doi: 10.3109/10715762.2015.1100730. Epub 2015 Nov 4. doi: 10.1177/0300060513476992. Epub 2013 Jan 24. doi: 10.1021/ol503291s. Epub 2014 Dec 19. doi: 10.1016/j.neulet.2015.12.052. Epub 2015 Dec 29.

    合成参考文献


    参考文献:10.1017/s0031182099006071
    摘要:Shaw MK, He CY, Roos DS, Tilney LG. Proteasome inhibitors block intracellular growth and replication of Toxoplasma gondii. Parasitology. 2000 Jul;121 ( Pt 1)():35–47. doi: 10.1017/s0031182099006071.
    参考文献:10.1073/pnas.97.24.13057
    摘要:Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, Princiotta MF, Bennink JR, Kräusslich H, Yewdell JW. Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U.S.A. 2000 Nov 21;97(24):13057–62. doi: 10.1073/pnas.97.24.13057.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知